Sarah Fendrick

Sarah Fendrick is a seasoned legal professional with extensive experience in patent counsel. Currently serving as Senior Director at Alnylam Pharmaceuticals since July 2022, Sarah Fendrick previously held the position of Director, Patent Counsel. Prior to this role, Sarah Fendrick practiced as an attorney at McDonnell Boehnen Hulbert & Berghoff LLP from September 2009 to June 2022. Sarah Fendrick holds a Juris Doctor degree from The Ohio State University Moritz College of Law, obtained in 2009, a Ph.D. in Neuroscience from the University of Florida, earned in 2006, and a Bachelor of Science in Genetics from the University of Wisconsin-Madison, completed in 2002.